Desk› Healthcare› Alivus Life Sciences Ltd
Alivus Life Sciences Ltd
Filing rhythm · 30 trading days
23 filings · 7 material · busiest 2026-07-30
What it files
Filings
23 in the window
-
25 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meetings
Company Update / Analyst / Investor Meet View filing →
-
18 August 2026
AcquisitionAcquisition
Enclosed please find herewith intimation pursuant to Regulation 30 of SEBI (LODR), 2015 with respect to acquisition.
Company Update / Acquisition View filing →
-
18 August 2026
Press ReleasePress Release / Media Release
Enclosed please find herewith Press Release with respect to Acquisition.
Company Update / Press Release / Media Release View filing →
-
13 August 2026
Newspaper PublicationNewspaper Publication
Please find enclosed herewith Newspaper Advertisement of Notice of 15th Annual General Meeting and E-Voting information.
Company Update / Newspaper Publication View filing →
-
13 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting
Company Update / Analyst / Investor Meet View filing →
-
11 August 2026
AGM / EGMNotice Of 15Th Annual General Meeting Of The Company For FY 2025-26 As Required Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find attached herewith Notice convening the 15th Annual General Meeting.
AGM/EGM / AGM View filing →
-
11 August 2026
Annual ReportReg. 34 (1) Annual Report.
Please find enclosed herewith Integrated Annual Report FY 2025-26 under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others / Reg. 34 (1) Annual Report View filing →
-
11 August 2026
BRSRBusiness Responsibility and Sustainability Reporting (BRSR)
Please find enclosed herewith the Business Responsibility & Sustainability Report for FY 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
7 August 2026
Concall TranscriptEarnings Call Transcript
Please find attached herewith transcript of Earnings call held on 31 July, 2026.
Company Update / Earnings Call Transcript View filing →
-
7 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Please find attached herewith details of Analyst/Investor meet.
Company Update / Analyst / Investor Meet View filing →
-
7 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Enclosed please find herewith details of investor meet.
Company Update / Analyst / Investor Meet View filing →
-
6 August 2026
AGM / EGMIntimation Of 15Th Annual General Meeting And Record Date.
Intimation of 15th Annual General Meeting and Record date.
AGM/EGM / AGM View filing →
-
6 August 2026
Record DateIntimation Of Record Date For Dividend
Intimation of Record date for Dividend.
Corp. Action / Record Date View filing →
-
6 August 2026
Newspaper PublicationNewspaper Publication
Newspaper Advertisement for 15th Annual General Meeting (AGM)
Company Update / Newspaper Publication View filing →
-
31 July 2026
Analyst / Investor MeetAnalyst / Investor Meet - Outcome
We hereby confirm that we have uploaded audio recording of the Q1 FY2027 Earnings Call held on July 31, 2026 on the website of the Company.
Company Update / Analyst / Investor Meet View filing →
-
30 July 2026
Board OutcomeBoard Meeting Outcome for Unaudited Financial Results For The First Quarter Ended June 30, 2026
Enclosed please find herewith unaudited financial results for the first quarter ended June 30, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
30 July 2026
ResultsUnaudited Financial Results For The First Quarter Ended June 30, 2026.
Enclosed please find herewith unaudited financial results for the first quarter ended June 30, 2026.
Result / Financial Results View filing →
-
30 July 2026
Press ReleasePress Release / Media Release
Enclosed please find herewith Press Release of the Company for the first quarter ended June 30, 2026.
Company Update / Press Release / Media Release View filing →
-
30 July 2026
Investor PresentationInvestor Presentation
Enclosed please find herewith Investors Presentation for Q1 FY 2026-27.
Company Update / Investor Presentation View filing →
-
30 July 2026
ESOP AllotmentAllotment of ESOP / ESPS
Enclosed please find herewith intimation with respect to allotment of equity shares under 'Employee Stock Options Scheme, 2021'
Company Update / Allotment of ESOP / ESPS View filing →
-
23 July 2026
Board MeetingBoard Meeting Intimation for Considering And Approving Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2026.
Alivus Life Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Board Meeting / Board Meeting View filing →
-
23 July 2026
Trading WindowClosure of Trading Window
Intimation of closure of Trading Window from 1st July, 2026 to 1st August, 2026 (both days inclusive), for the purpose of approval of unaudited financial results for the quarter ended 30th June, 2026.
Insider Trading / SAST / Closure of Trading Window View filing →
-
23 July 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Enclosed please find herewith the details of Earnings Call slated for Friday, July 31, 2026 from 8:30 a.m. to 9:30 a.m. (IST), for your information and record.
Company Update / Analyst / Investor Meet View filing →